Mellinkoff GI and Hepatology Symposium

425 Westwood Plaza Los Angeles, CA 90095

11th Annual UCLA-Mellinkoff GI and Hepatology Symposium Brochure (PDF)

The 11th Annual UCLA-Mellinkoff Gastroenterology and Hepatology Symposium is designed to offer healthcare professionals novel and integrative approaches to treat common GI disorders that can easily be implemented into practice and have significant impact on patient outcomes. In addition, an endoscopy forum with video and live cases will showcase complex cases and new technology. Interactive, lively case-based presentations and debates by experts in their field will engage attendees and enhance this learning experience.

The symposium is a hybrid event and can be accessed through a live, virtual meeting web platform. Registrants will receive a virtual meeting link and password to access the conference and virtual exhibit hall.

The hands-on session and industry-supported lecture will provide valuable learning opportunities, though no accredited hours will be issued for these portions.


Gastroenterologists, GI endoscopists, hepatologists, GI physician assistants, GI nurse practitioners, GI nurses, GI fellows, and other allied healthcare professionals.


Course Fees


  • $400 - MD/DO ($350 for UCLA GI fellow alumni)
  • $300 - Other healthcare professions
  • Complimentary - Fellows/trainees (email:


Enroll Online

MD, DO and Other Healthcare Professions: Online Registration

Fellows and Trainees


If you have questions about the exhibitor opportunities, please call (310) 794-2620 or email


At the end of the course, learners will be able to:

  • Discuss the current medical management and nutrition counseling guidelines for treating patients with IBD; including special populations including pregnancy and older patients
  • Describe the latest diagnostic, therapeutic and nutrition advances to treat esophageal disorders 
  • Apply the latest pharmacological, dietary, and brain-gut behavioral management strategies to treat functional GI disorders and overlapping disorders
  • Demonstrate a structured approach for the evaluation and treatment of patients with liver disorders 
  • Apply the current colon and rectal cancer screening guidelines and the interdisciplinary management strategies for polyp detection
  • Discuss the current guidelines and recommended screening protocols for pancreas cancer
  • Discuss advanced therapeutic endoscopy options to treat patients with gastrointestinal disorders


CME Credits

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


The California State Board of Registered Nursing accepts courses approved by the AMA for Category 1 Credit(s) as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies. Nursing participants, who attend both days in full, will be awarded 15 CMEs. Partial credit is not available. For more information, please visit the California BRN website or contact Kathleen Feldman, MSN, RN, NPD-BC, at


The FDA has issued a concept paper which classified commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the sponsor adequately manage all identified potential conflicts of interest prior to the program. We, at UCLA, fully endorse the letter and spirit of these concepts.